Human cytochrome P450s: selectivity and measurement in vivo
- 1 January 1998
- journal article
- review article
- Published by Taylor & Francis in Xenobiotica
- Vol. 28 (12) , 1095-1128
- https://doi.org/10.1080/004982598238859
Abstract
No abstract availableKeywords
This publication has 78 references indexed in Scilit:
- Cytochrome P-450 hPCN3, a Novel Cytochrome P-450 IIIA Gene Product That Is Differentially Expressed in Adult Human Liver: cDNA and deduced amino acid sequence and distinct specificities of cDNA-expressed hPCN1 and hPCN3 for the metabolism of steroid hormones and cyclosporinPublished by Elsevier ,2021
- Geographical/Interracial Differences in Polymorphic Drug OxidationClinical Pharmacokinetics, 1995
- Clozapine disposition covaries with CYP1A2 activity determined by a caffeine test.British Journal of Clinical Pharmacology, 1994
- Diazepam metabolism by human liver microsomes is mediated by both S‐ mephenytoin hydroxylase and CYP3A isoforms.British Journal of Clinical Pharmacology, 1994
- Polymorphic debrisoquin metabolism in a turkish populationClinical Pharmacology & Therapeutics, 1994
- Cortisol metabolism by human liver in vitro—I. Metabolite identification and inter-individual variabilityThe Journal of Steroid Biochemistry and Molecular Biology, 1992
- Polymorphic hydroxylation of S-mephenytoin and omeprazole metabolism in Caucasian and Chinese subjectsPharmacogenetics, 1992
- Comparative effects of the antimycotic drugs ketoconazole, fluconazole, itraconazole and terbinafine on the metabolism of cyclosporin by human liver microsomes.British Journal of Clinical Pharmacology, 1991
- A population study of the pharmacokinetics of felodipine.British Journal of Clinical Pharmacology, 1991
- Importance of genetic factors in the regulation of diazepam metabolism: Relationship to S-mephenytoin, but not debrisoquin, hydroxylation phenotypeClinical Pharmacology & Therapeutics, 1989